Heghine Khachatryan: World Federation of Hemophilia Is Far More Than An Organization
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from WFH on LinkedIn:
”WFH’s work consistently reinforces a critical truth:
bleeding disorders are not only medical conditions — they are issues of health equity, gender equity, and human rights.
-For clinicians, WFH represents knowledge, standards, and professional growth
-For patients, it provides voice, visibility, and dignity
– For health systems, it offers a sustainable model for organizing rare disease care.
World Federation of Hemophilia (WFH) is far more than an organization — it is a global movement that has fundamentally transformed the lives of people living with hemophilia and other inherited bleeding disorders worldwide.
As 2025 comes to a close, WFH’s impact is particularly evident in several key areas:
• increasing global awareness of hemophilia and bleeding disorders,
• addressing the long-standing underdiagnosis of bleeding disorders in women and girls,
• strengthening continuous medical education for healthcare professionals,
• advancing laboratory standards, clinical guidelines, and evidence-based care, and
• expanding equitable access to safe and effective treatment.
With gratitude for WFH’s global leadership, collaboration, and unwavering commitment to patient-centered care.”
Qutoing World Federation of Hemophilia‘s post:
”As 2025 comes to a close, the World Federation of Hemophilia is celebrating a year of meaningful progress for people with hemophilia and Bleeding Disorders around the world.
Thanks to our global community, partners, and volunteers, this year saw important milestones, from expanding diagnosis and care to strengthening humanitarian aid and advancing treatment standards.
Read more.
Wishing our community a bright start to 2026, we look forward to connecting with you in Malaysia for the WFH 2026 World Congress!”
Stay updated with Hemostasis Today.
-
May 30, 2026, 10:27Sartaj Alam: CBC Analyzer – The Backbone of Modern Hematology Diagnostics
-
May 30, 2026, 10:17Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
-
May 30, 2026, 10:06Johann Morelle: Complement Inhibitors Are Reshaping Modern Nephrology
-
May 30, 2026, 09:49Flora Peyvandi: Exploring a Multidisciplinary Care Model for Hemophilia and Rare Diseases
-
May 30, 2026, 08:59Li-Chia Chen: Advancing Patient Care Through Pharmacist Innovation at KUTRRH
-
May 30, 2026, 08:58Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
-
May 30, 2026, 08:56Reidiel Suárez Borges: Understanding the INR in Anticoagulation Management
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center